Advancing Womens Health Through Validated Non Invasive Diagnostic

The shift toward non-invasive diagnostics

Healthcare systems worldwide are increasingly prioritizing diagnostics that are less invasive, more accessible and better aligned with preventive care. Non-invasive approaches can reduce patient burden, remove barriers to testing and enable longitudinal monitoring. When properly validated, they support earlier detection and improved treatment compliance. However, innovation in diagnostics only becomes clinically meaningful when it is supported by rigorous scientific validation and structured quality assurance frameworks.

For decades, women’s health has been underserved by diagnostic research, resulting in persistent data gaps across female-specific conditions. Addressing this imbalance requires validated tools that clinicians can rely on for reproducible and clinically interpretable results. By applying high-quality standards and scientific rigor from the outset, menstrual blood diagnostics have the potential to enable earlier detection, strengthen clinical understanding and improve care delivery.

Menstrual blood as an emerging diagnostic matrix

Menstrual blood is gaining attention as a biologically relevant and informative diagnostic matrix. Unlike peripheral blood, it originates directly from the uterine environment and reflects cyclical inflammatory and tissue remodeling processes. This biological proximity makes it particularly relevant for investigating female-specific and inflammation‑related conditions. At the same time, its novelty introduces analytical and regulatory challenges that must be resolved before routine clinical adoption. Questions related to reproducibility, sample integrity, analytical robustness and clinical interpretation must be addressed through clearly defined validation frameworks aligned with applicable regulatory guidance. Without this foundation, promising non-invasive methods may remain experimental rather than transitioning into routine healthcare practice.

Validation as the foundation of clinical trust

For any emerging diagnostic matrix, validation serves as the critical bridge between scientific promise and clinical applicability. It is not a procedural formality but a prerequisite for credibility and regulatory acceptance. Scientific and regulatory stakeholders require evidence that bioanalytical methods generate accurate, reproducible and clinically interpretable results under controlled, quality‑assured conditions. Positioning validation at the core of development ensures consistency, supports regulatory acceptance, strengthens clinician confidence and ultimately safeguards patients. Embedding rigorous methodologies early in the development process enables innovation to progress responsibly and sustainably, particularly when working with novel matrices such as menstrual blood. 

Our partnership with the blood

We are proud to be collaborating with Berlin-based health tech startup, the blood, to advance menstrual blood diagnostics using the same rigorous scientific standards applied to established biological matrices. Leveraging our global pharmaceutical bioanalytical expertise, we provide independent quality oversight and validation support to ensure these emerging diagnostics are developed and evaluated in a structured and credible way. By embedding robust validation strategies from the earliest stages, we help menstrual blood diagnostics mature within a reliable and regulatory-aligned development pathway. 

SGS solutions

Insure reliable menstrual blood diagnostics with trusted bioanalytical expertise. Our global teams apply validated methods for method development, validation and sample‑integrity assessment, evaluating accuracy, precision, sensitivity, specificity and reproducibility in line with international regulatory and quality standards. We implement rigorous quality‑assurance practices from the outset, ensuring diagnostic development proceeds under controlled, compliant and transparent conditions. This foundation helps emerging menstrual blood diagnostics advance confidently toward clinical application while maintaining scientific credibility and regulatory compliance. Our experts support the full lifecycle of diagnostic development, helping healthcare and research stakeholders navigate complex requirements and bring innovative approaches to market with confidence.